These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2474144)

  • 21. Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide.
    Andén NE; Corrodi H; Fuxe K; Hökfelt T
    Br J Pharmacol; 1968 Sep; 34(1):1-7. PubMed ID: 5302837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examination of tonic nociceptive behavior using a method of substance P-receptor desensitization in the dorsal horn.
    Holland LN; Goldstein BD
    Pain; 1994 Mar; 56(3):339-346. PubMed ID: 7517516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization.
    Moochhala SM; Sawynok J
    Br J Pharmacol; 1984 Jun; 82(2):381-8. PubMed ID: 6203593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal cord SP release and hyperalgesia in monoarthritic rats: involvement of the GABAB receptor system.
    Malcangio M; Bowery NG
    Br J Pharmacol; 1994 Dec; 113(4):1561-6. PubMed ID: 7534191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of C- and N-terminal substance P metabolites on the release of amino acid neurotransmitters from the spinal cord: potential role in nociception.
    Skilling SR; Smullin DH; Larson AA
    J Neurosci; 1990 Apr; 10(4):1309-18. PubMed ID: 1691775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between serotonin and substance P in the spinal regulation of nociception.
    Eide PK; Hole K
    Brain Res; 1991 Jun; 550(2):225-30. PubMed ID: 1715803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice.
    Gamse R; Saria A
    Neurosci Lett; 1986 Sep; 70(1):143-7. PubMed ID: 2430237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord.
    Inoue M; Shimohira I; Yoshida A; Zimmer A; Takeshima H; Sakurada T; Ueda H
    J Pharmacol Exp Ther; 1999 Oct; 291(1):308-13. PubMed ID: 10490918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desensitization to substance P following intrathecal injection. A technique for investigating the role of substance P in nociception.
    Sawynok J; Robertson G
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):152-8. PubMed ID: 2418368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
    Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An N-terminal fragment of substance P, substance P(1-7), down-regulates neurokinin-1 binding in the mouse spinal cord.
    Yukhananov RYu ; Larson AA
    Neurosci Lett; 1994 Aug; 178(1):163-6. PubMed ID: 7529387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactive calcitonin gene-related peptide and substance P coexist in sensory neurons to the spinal cord and interact in spinal behavioral responses of the rat.
    Wiesenfeld-Hallin Z; Hökfelt T; Lundberg JM; Forssmann WG; Reinecke M; Tschopp FA; Fischer JA
    Neurosci Lett; 1984 Nov; 52(1-2):199-204. PubMed ID: 6084836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of substance P by intrathecal KK-3, a newly synthesized Leu-enkephalin derivative.
    Takahashi M; Tokuyama S; Kaneto H
    Pharmacol Biochem Behav; 1989 Aug; 33(4):843-6. PubMed ID: 2482510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The preservation of substance P by lysergic acid diethylamide.
    KRIVOY WA
    Br J Pharmacol Chemother; 1957 Sep; 12(3):361-4. PubMed ID: 13460245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Correlation between activation of L5-S2 spinal cord astrocytes and effect of substance P in chronic prostatitis pain].
    Zhang H; Liu LM; Lu GS; Xiong EQ; Li WB; Zhou ZS; Zhang JH; Pan JH; Chen ZW; Li LK; Yang Z; Song B
    Zhonghua Nan Ke Xue; 2009 Nov; 15(11):1021-7. PubMed ID: 20218316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats.
    Krebs KM; Geyer MA
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Elliott SP; Hoang K; Wallach J; Halberstadt AL
    Drug Test Anal; 2016 Sep; 8(9):891-902. PubMed ID: 26456305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The action of LSD on the isolated frog spinal cord: electrophysiological and ultrastructural data.
    de Santis A; Kemali M
    Gen Pharmacol; 1982; 13(3):255-5. PubMed ID: 7095403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pharmacologic comparison of 3,4-methylenedioxyamphetamine and LSD in the chronic spinal dog.
    Nozaki M; Vaupel DB; Martin WR
    Eur J Pharmacol; 1977 Dec; 46(4):339-49. PubMed ID: 590343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.